Novel 1,4-disubstituted piperazine compounds and pharmaceutical compositions incorporating such compounds in conjunction with orally, parenterally or rectally administrable pharmaceutically acceptable carriers are disclosed. These compounds have coronary vasodilating properties. Also disclosed are processes for preparing these compounds, and novel intermediate compounds used in such processes.
本发明揭示了一种新颖的1,4-二取代
哌嗪化合物以及包含这些化合物的制药组合物,与口服、注射或直肠给药的药学可接受载体结合使用。这些化合物具有冠状动脉扩张作用。本发明还揭示了制备这些化合物的方法,以及用于这些方法的新型中间体化合物。